Concepedia

Publication | Open Access

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma

16

Citations

30

References

2023

Year

Abstract

These findings encourage further development of NK-92/5.28.z cells as off-the-shelf immunotherapy for the treatment of metastatic RMS.

References

YearCitations

Page 1